SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SCHULER JACK W
(Last) (First) (Middle)
PO BOX 531
(Street)
LAKE BLUFF IL 60044
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Aspira Women's Health Inc. [ AWH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/06/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 6,536 D
Common Stock 1,912,156 I By Jack W. Schuler Living Trust(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Senior Secured Convertible Note due 2030 $0.25 03/06/2025 P $200,000 03/06/2025 03/06/2030 Common Stock(2) 800,000(2) $200,000 $200,000 I By Jack W. Schuler Living Trust(1)
Warrant (Right to Buy) $2.25 07/09/2024 07/09/2027 Common Stock 6,536 6,536 D
Warrant (Right to Buy) $4.13 07/26/2024 07/26/2029 Common Stock 28,500 28,500 I By Jack W. Schuler Living Trust(1)
Warrant (Right to Buy) $4.13 08/25/2022 01/26/2029 Common Stock 8,888 8,888 I By Jack W. Schuler Living Trust(1)
Explanation of Responses:
1. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.
2. On March 6, 2025, the Issuer issued to the Living Trust in a private transaction a Senior Secured Convertible Note due 2030 in the principal amount of $200,000 (the "Convertible Note"). Each $0.25 principal amount of the Convertible Note is convertible by its holder at any time prior to maturity into one "Phase 1 Unit," consisting of (i) one share of Common Stock and (ii) a warrant to purchase, on the terms set forth therein, 2.25 shares of Common Stock.
/s/ Jack W. Schuler 03/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Aspira Womans Health (NASDAQ:AWH)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Aspira Womans Health Charts.
Aspira Womans Health (NASDAQ:AWH)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Aspira Womans Health Charts.